Merck's Vioxx Pain Control Is Superior To Endo's Percocet, Reps Tell Doctors

Merck's attempts to boost the performance of Vioxx include sales rep distribution of data supporting the COX-2 inhibitor's superiority to Endo's Percocet, Senior Director-Investor Relations Laura Jordan told analysts during an Oct. 18 earnings call.